Form 4: Director Margaret Liu Acquires Macrogenics Stock

Director Margaret Liu reported a transaction involving Macrogenics Inc. common stock, acquiring 3,750 shares through vested Restricted Stock Units.

Summary

• Director Margaret Liu acquired 3,750 shares of Macrogenics Inc. common stock on May 18, 2026.
• The acquisition was made through the vesting of Restricted Stock Units (RSUs).
• Following this transaction, Liu beneficially owns 14,750 shares of common stock.
• Additionally, Liu holds 22,000 shares through stock options.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions related to compensation and vesting schedules rather than significant strategic shifts or financial performance indicators.

Positives

• Director acquisition of company stock can signal confidence in the company's future prospects.
• Vesting of RSUs and exercise of stock options indicate that performance or time-based vesting conditions have been met.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which primarily reports on past transactions.

Industry Context

StockSavvy.ai notes that insider transactions, such as this Form 4 filing by Director Margaret Liu, are common in the biotechnology and pharmaceutical sectors as a means of executive compensation and alignment with shareholder interests. The acquisition of stock by a director can be interpreted as a positive signal regarding the company's internal valuation.

Stakeholder Impact

• Shareholders: The acquisition of stock by a director may be viewed positively, suggesting insider confidence in the company's value.

Key Dates

Keywords

Macrogenics Inc., MGNX, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Beneficial Ownership, Director Transaction